Effectiveness of a Digital Health Application for Primary Hypertension (Liebria)
← catalyst calendarSponsored by Gaia AG (industry) · GAIA — their whole pipeline →. With University Hospital Schleswig-Holstein, Charite University, Berlin, Germany.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
328estimated
Sites
1
Country
Germany
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-04-02 | actual | When the study began enrolling |
| Primary completion | Jun 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2024-02-06 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-16 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Hypertension
Interventions
- Behavioral: liebria
- Other: information brochure on hypertension
Primary outcome
what the primary-completion date above is the date OFSBP (in mmHg)
measured 6 months
Permalink · GAIA's whole pipeline · Catalyst calendar · Every registered study · What changed